{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:28:27Z","timestamp":1648632507242},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1093\/jac\/dkp456","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T03:58:54Z","timestamp":1260935934000},"page":"347-349","source":"Crossref","is-referenced-by-count":5,"title":["A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists"],"prefix":"10.1093","volume":"65","author":[{"given":"A.","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alleyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"key\n\t\t\t\t20170425183629_DKP456C1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/AAC.34.12.2348","article-title":"Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination","volume":"34","author":"Cantoni","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183629_DKP456C2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms","volume":"29","author":"Gonzalez","year":"1990","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425183629_DKP456C3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jac\/dkf215","article-title":"The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin","volume":"50","author":"Moise","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183629_DKP456C4","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425183629_DKP456C5","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170425183629_DKP456C6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkp065","article-title":"Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom","volume":"63","author":"Gould","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425183629_DKP456C7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20170425183629_DKP456C8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jhin.2006.01.001","article-title":"Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities","volume":"63","author":"Coia","year":"2006","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20170425183629_DKP456C9","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425183629_DKP456C10","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1086\/506568","article-title":"Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious disease consultants","volume":"43","author":"Hageman","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/2\/347\/13759378\/dkp456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T08:22:16Z","timestamp":1503476536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkp456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,15]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,12,15]]},"published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkp456","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,15]]}}}